Status:
COMPLETED
Prevention of Catheter-Related Bloodstream Infection in Patients With Haemato-Oncological Disease
Lead Sponsor:
Centre National de Greffe de Moelle Osseuse
Conditions:
Infection
Eligibility:
All Genders
4-60 years
Phase:
PHASE3
Brief Summary
We, the researchers at Centre National de Greffe de Moelle Osseuse, have shown in a randomised study (in press), that a low dose of unfractionated heparin (100 IU/kg/daily) was safe and effective to p...
Detailed Description
Studies have shown that catheter-related infection may be due to fibrin deposition associated with catheters. Interventions designed to decrease fibrin deposition and thrombus formation have the poten...
Eligibility Criteria
Inclusion
- Age between 4 and 60 years
- Short term non-tunneled percutaneous central venous catheter
Exclusion
- Presence of a central venous catheter at admission
- Major blood coagulation disorders (platelet count \< 50 x 10\^9, disseminated intravascular coagulation)
- Absence of catheter-tip culture at the time of catheter removal
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
End Date :
August 1 2005
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00207779
Start Date
May 1 2005
End Date
August 1 2005
Last Update
September 20 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre National de Greffe de Moelle Osseuse
Tunis, Tunis Governorate, Tunisia, 1006